Exact Mass: 276.1397028
Exact Mass Matches: 276.1397028
Found 500 metabolites which its exact mass value is equals to given mass value 276.1397028
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sudan_II
C.i. solvent orange 7 appears as red crystals. Insoluble in water. Sudan II is a member of azobenzenes.
Saccharopine
Saccharopine is an intermediate in the degradation of lysine, formed by the condensation of lysine and alpha-ketoglutarate. The saccharopine pathway is the main route for lysine degradation in mammals, and its first two reactions are catalyzed by enzymatic activities known as lysine-oxoglutarate reductase (LOR) and saccharopine dehydrogenase (SDH), which reside on a single bifunctional polypeptide (LOR/SDH) (EC 1.5.1.8). The reactions involved with saccharopine dehydrogenases have very strict substrate specificity for L-lysine, 2-oxoglutarate, and NADPH. LOR/SDH has been detected in a number of mammalian tissues, mainly in the liver and kidney, contributing not only to the general nitrogen balance in the organism but also to the controlled conversion of lysine into ketone bodies. A tetrameric form has also been observed in human liver and placenta. LOR activity has also been detected in brain mitochondria during embryonic development, and this opens up the question of whether or not lysine degradation has any functional significance during brain development. As a result, there is now a new focus on the nutritional requirements for lysine in gestation and infancy. Finally, LOR and/or SDH deficiencies seem to be involved in a human autosomal genetic disorder known as familial hyperlysinemia, which is characterized by serious defects in the functioning of the nervous system and characterized by a deficiency in lysine-ketoglutarate reductase, saccharopine dehydrogenase, and saccharopine oxidoreductase activities. Saccharopinuria (high amounts of saccharopine in the urine) and saccharopinemia (an excess of saccharopine in the blood) are conditions present in some inherited disorders of lysine degradation (PMID: 463877, 10567240, 10772957, 4809305). If present in sufficiently high levels, saccharopine can act as an acidogen and a metabotoxin. An acidogen is an acidic compound that induces acidosis, which has multiple adverse effects on many organ systems. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Saccharopine is an organic acid. Abnormally high levels of organic acids in the blood (organic acidemia), urine (organic aciduria), the brain, and other tissues lead to general metabolic acidosis. Acidosis typically occurs when arterial pH falls below 7.35. In infants with acidosis, the initial symptoms include poor feeding, vomiting, loss of appetite, weak muscle tone (hypotonia), and lack of energy (lethargy). Many affected children with organic acidemias experience intellectual disability or delayed development. Amino acid from Saccharomyces cerevisiae and Neurospora crassaand is also found in mushrooms and seeds
4-Hydroxycinnamoylagmatine
4-Hydroxycinnamoylagmatine is found in cereals and cereal products. 4-Hydroxycinnamoylagmatine is isolated from barley seedlings. Isolated from barley seedlings. 4-Hydroxycinnamoylagmatine is found in cereals and cereal products.
Triethyl citrate
Triethyl citrate is used in foods as a flavouring agent, solvent and surface-active agent Triethyl citrate is an ester of citric acid. It is a colorless, odorless liquid used as a food additive (E number E1505) to stabilize foams, especially as whipping aid for egg white. In pharmaceutical coatings and plastics It is used in foods as a flavouring agent, solvent and surface-active agent
Acetylpterosin C
Acetylpterosin C is found in green vegetables. Acetylpterosin C is from Pteridium aquilinum (bracken fern
Mebhydrolin
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Mebhydrolin is a first-generation antihistamine. Mebhydrolin is a specific histamine H1 receptor antagonist.
1-[(2,5-Dimethylphenyl)azo]-2-naphthalenol
1-[(2,5-Dimethylphenyl)azo]-2-naphthalenol is a food dye; delisted for foods by FDA. Food dye; delisted for foods by FDA
N-lactoyl-Tryptophan
N-lactoyl-Tryptophan is lactoyl derivative of tryptophan. N-lactoyl-amino acids are ubiquitous pseudodipeptides of lactic acid and amino acids that are rapidly formed by reverse proteolysis. A protease, cytosolic nonspecific dipeptidase 2 (CNDP2), catalyzes their formation. The plasma levels of these metabolites strongly correlate with plasma levels of lactate and amino acid. (PMID: 25964343)
5-Benzylacyclouridine
D004791 - Enzyme Inhibitors
9-Methoxyellipticine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines
2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-fluoroaniline
C15H17FN2S (276.10964140000004)
Etintidine
N-(4-Aminobutyl)-N-ethylisoluminol
Cyclo(Tyr-Leu)
Cyclo(Tyr-Leu) is a natural product found in Nocardia alba and Portulaca oleracea with data available. Cyclo(Tyr-Leu) is a cyclic dipeptide[1]. Cyclo(Tyr-Leu) is a cyclic dipeptide[1]. Cyclo(Tyr-Leu) is a cyclic dipeptide[1].
1-(5,7-dihydroxy-2,2,6-trimethyl-2 h -1-benzopyran-8-yl)-2-methyl-1-propanone
(4S,4aR,6R)-1-acetyl-6-(acetyloxy)-4,4a,5,6-tetrahydro-4,7-dimethylnaphthalen-2(3H)-one|eupatorone
Ac-1beta-1-Hydroxy-13-nor-6,9-eremophiladiene-8,11-dione
3-(3-Methyl-2-butenyl)-4-isobutyryloxybenzoic acid
8-hydroxy-3,7-dimethoxy-1,2,3,11a-tetrahydro-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5-one|Methyl-Neotramizin A|Methyl-Neotramizin B
(2E,2E)-4-Me ether,Me ester-3-[4-Hydroxy-3-(4-hydroxy-3-methyl-2-buteny)phenyl]-2-propenoic acid|methyl 3-(4-hydroxyprenyl)-coumarate 4-O-methyl ether
8,12-epoxy-1alpha-methoxy-4alphaH,5alphaH-eudesma-7,11-dien-6,9-dione
6,8-Dimethoxy-3-isobutyl-2-methyl-4H-1-benzopyran-4-one
2,3-Dihydro-5,7-dihydroxy-2,6-dimethyl-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
(S)-Aspertetronin A|2-[(1E,3E)-hexa-1,3-dien-1-yl]-5-methoxy-2-methyl-4-[(2E)-1-oxobut-2-en-1-yl]furan-3-(2H)-one|aspertetronin A
9-Methoxyellipticine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D004611 - Ellipticines
2-Methyl-2-isobutyryl-6,7-dimethoxy-2H-1-benzopyran
methyl (4R,5S,6R,7R,11S)-2,9-dioxo-1(10)-aromadendren-12-oate
(+)-(S)-8,9-dihydro-9-phenyl-7H-phenalene-1,2-diol|monolaterol
2,3-Dihydro-5,7-dihydroxy-2,8-dimethyl-6-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one
Chlorajapolide F
3beta-acetoxy-6,9-dien-8-oxoeremophil-12-nor-11-one
2,2-dimethyl-6-hydroxy-8-(3-hydroxy-3-methyl-1E-butenyl)-chromanone
4-hydroxy-2-(3-hydroxy-2-methoxy-3-methyl-butylidene)-3,4-dihydro-2h-naphthalen-1-one
norpinguisone acetate
A natural product found in Porella chilensis and Porella recurva.
(3aR,4S,5aR,10aR,10bR)-3,3a,4,5,5a,9,10,10b-octahydro-3a,4,10b-trimethyl-2H,7H-naphtho[4a,4-b:1,8-b?c?]difuran-2,7-dione|ciliatolide A
3-crotonoyl-5-<(1E,3E)-hexa-1,3-dienyl>-4-methoxy-5-methylfuran-2(5H)-one|iso-aspertetronin A
2-methyl-6-hydroxycyclohexenyl-3-methyl-1-acetophenone ether
3-oxo-8alpha-methoxy-10aH-eremophila-1,7(11)-dien-12,8beta-olide|3-oxo-8alpha-methoxy-10alphaH-eremophila-1,7(11)-dien-12,8beta-olide|8beta-hydroxy-8alpha-methoxy-3-oxo-eremophil-1,7(11)-dien-12-oic acid lactone
13,14,15,16-tetranorlabd-7-en-(19,6beta),(12,17)-diolide|13,14,15,16-tetranorlabd-7-en-16,6beta:12,17-diolide|13,14,15,16-tetranorlabd-7-ene-19,6b:12,17-diolide
2-isopropyl-9S-methoxy-7R-methyl-6,7-dihydro-2H-furo[3,2-h]isochromen-3(9H)-one|ustusorane D
6-Deoxy-2-O-methyl-3-C-methuyltalose, 9CI-1,4-Di-Ac
2,3-Dihydro-6,7-dimethoxy-2-methyl-2-(2-methyl-1-propenyl)-4H-1-benzopyran-4-one
1,6-dichloro-1,6-dimethyl-4-(propan-2-yl)decahydronaphthalene
2-hexyl-5-hydroxy-7-methoxy-4H-1-benzopyran-4-one|5-hydroxy-2-hexyl-7-methoxy-4-chromone
2,2-Dimethyl-5-methoxy-2H-1-benzopyran-6-propionic acid methyl ester
methyl-3-<3,3-dimethyl-3-hydroxyallyl>-p-coumarate-O-methyl ether
Triethylcitrate
CONFIDENCE standard compound; INTERNAL_ID 2857 CONFIDENCE standard compound; INTERNAL_ID 8781
ascr#1
An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (6R)-6-hydroxyheptanoic acid with ascarylopyranose (the alpha anomer). It is a major component of the dauer pheromone, used by the nematode Caenorhabditis elegans as a population-density signal to promote entry into an alternate larval stage, the nonfeeding and highly persistent dauer diapause. It has also been found in Pristionchus pacificus and the sour paste nematode Panagrellus redivivus. CONFIDENCE standard compound; INTERNAL_ID 97
Gly Gly Gly Ser
C9H16N4O6 (276.10697960000005)
Gly Ser Gly Gly
C9H16N4O6 (276.10697960000005)
Mebhydrolin
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Mebhydrolin is a specific histamine H1 receptor antagonist.
SC-66
SC66 is an Akt inhibitor, reduces cell viability in a dose- and time-dependent manner, inhibits colony formation and induces apoptosis in hepatocellular carcinoma (HCC) cells.
oscr#1
An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 7-hydroxyheptanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.
3-(2-TriMethylsilanyl-ethoxyMethyl)-6-vinyl-3H-[1,2,3]triazolo[4,5-b]pyridine
(1R,5S)-5-(Dimethylphenylsilyl)-2-(hydroxymethyl)-2-cyclopentene-1-carboxylic acid
C15H20O3Si (276.11816500000003)
Taglutimide
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
1,2,3,6,7,8,11,12-OCTAHYDROBENZO[E]PYREN-9(10H)-ONE
Oxagrelate
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
dimethyl 1-allyl-5,5-difluorocyclohexane-1,3-dicarboxylate
tert-butyl 2-(3-amino-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl)acetate
1-(tert-Butoxycarbonyl)-5-methyl-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid
2-(4-(PIPERAZIN-1-YL)PHENYL)PYRIMIDINE HYDROCHLORIDE
Urea, N-(3-fluorophenyl)-N-[3-(2-furanyl)-1-methylpropyl]- (9CI)
methyl 3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
METHYL 2-((4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)METHYL)BENZOATE
1-TERT-BUTYL 5-METHYL 1H-INDAZOLE-1,5-DICARBOXYLATE
[(2S)-1-(4-nitrophenyl)pyrrolidin-2-yl]methyl prop-2-enoate
1-Benzyl-3-methylpiperidin-4-ylamine dihydrochloride
Methyl 2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine
(4-Methoxycarbonylmethyl)phenylboronic acid pinacol ester
methyl 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
4-(METHOXYCARBONYL)-2-METHYLPHENYLBORONIC ACID PINACOL ESTER
METHYL 2-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETATE
METHYL 2-(2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETATE
N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinamide
3-(1,3-Dioxolan-2-yl)phenylboronic acid pinacol ester
3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid
N-(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)PROPIONAMIDE
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(trifluoromethyl)-1H-pyrazole
C11H16BF3N2O2 (276.12568619999996)
6-t-butyl-4-piperazinothieno[3,2-d]pyrimidine
C14H20N4S (276.14086000000003)
Benzoic acid, 2-Methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, Methyl ester
5-ethyl-1-(methoxymethyl)-5-phenyl-1,3-diazinane-2,4,6-trione
methyl 2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
5-methyl-5-[4-(3-methylbutoxy)phenyl]imidazolidine-2,4-dione
4-(1-ADAMANTYL)-6-(METHYLTHIO)-1,3,5-TRAZIN-2-AMINE
C14H20N4S (276.14086000000003)
(R)(2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER
ETHYL 3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
4-(Acetoxymethyl)benzeneboronic acid pinacol ester
4-(METHYLAMINO)-1-BENZYLPIPERIDINE DIHYDROCHLORIDE
ETHYL 4-(2-HYDROXYPHENYL)-6-METHYL-2-OXO-1,2,3,4-TETRAHYDROPYRIMIDINE-5-CARBOXYLATE
1-Butyl-3-methylimidazolium Trifluoro(trifluoromethyl)borate
N,N-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide
Ethyl 4-hydroxy-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
3,5-di(pyridin-2-yl)phenylboronic acid
C16H13BN2O2 (276.10700280000003)
5-[(2-methylpropan-2-yl)oxycarbonylamino]-1H-indole-2-carboxylic acid
6-(Ethylcarbamoyl)pyridine-3-boronic acid pinacol ester
1-Methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea
3-(2,5-dimethylphenyl)-1-phenylpyrazole-4-carbaldehyde
1-(tert-butyl-dimethyl-silanyl)-1h-pyrrolo[2,3-b]pyridin-5-yl boronic acid
1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(1,1-dimethylethyl)dimethylsilyl]-
C14H20N2O2Si (276.12939800000004)
2-([1,1-BIPHENYL]-4-CARBONYL)-3-(DIMETHYLAMINO)ACRYLONITRILE
(R)-1-Benzyl-3-dimethylaminopyrrolidine Dihydrochloride
1,8-Diazaspiro[4.5]decane-1-carboxylic acid, 1,1-dimethylethyl ester, (Hydrochloride) (1:1)
6-(3-(6-METHYLPYRIDIN-2-YL)-1H-PYRAZOL-4-YL)-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE
4,4,5,5-TETRAMETHYL-2-(4-(TRIFLUOROMETHYL)CYCLOHEX-1-EN-1-YL)-1,3,2-DIOXABOROLANE
Ethambutol hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent Ethambutol dihydrochloride (Emb dihydrochloride) is a bacteriostatic antimycobacterial agent, which obstructs the formation of cell wall by inhibiting arabinosyl transferases. Target: Antibacterial Ethambutol dihydrochloride (Emb dihydrochloride) directly affects two polymers, arabinogalactan (AG) and lipoarabinomannan (LAM) in Mycobacterium smegmatis. In M. smegmatis, Ethambutol inhibits synthesis of arabinan completely and inhibits AG synthesis most likely as a consequence of this; more than 50\% of the cell arabinan is released from the bacteria following Ethambutol treatment, whereas no galactan is released. Ethambutol main targets against embB gene product in M. avium. Ethambutol induces 60\% changes in the embB gene in M. tuberculosis resistant mutants [1]. Ethambutol dihydrochloride (Emb dihydrochloride) is effective against actively growing microorganisms of the genus Mycobacterium, including M. tuberculosis. Nearly all strains of M. tuberculosis and M. kansasii as well as a number of strains of the M. aviumcomplex (MAC) are sensitive to Ethambutol. [1] Ethambutol dihydrochloride (Emb dihydrochloride) is potency against M. tuberculosis (H37Rv) with MIC of 0.5 μg/mL in vitro [2]. Ethambutol is efficient on treatment of mycobacterial-infected macrophages. When M. tuberculosis infected macrophages are treated with 6 μg/mL Ethambutol, the log CFUs following treatment for 3 days is 4.17, while value in control group is 4.8. The MICs for M. avium (MTCC 1723) and M. smegmatis (MTCC 6) are 15 μg/mL and 0.18 μg/mL, respectively. Ethambutol is efficient in animal model. 100 mg/kg Ethambutol given orally 15 days post i.v. infection 1 ×/week for 5 weeks, induces a lower log CFU compared with untreatment (4.59 vs 5.07) [3].
4,4,5,5-TETRAMETHYL-2-(4-(OXIRAN-2-YLMETHOXY)PHENYL)-1,3,2-DIOXABOROLANE
methyl 2-tert-butyl-5-nitro-1H-indole-7-carboxylate
(2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPIN-3-YL)-CARBAMIC ACID TERT-BUTYL ESTER
2-acetamido-3-(6-Methoxy-1H-indol-3-yl)propanoic acid
4-(1-PIPERIDINYLMETHYL)-BENZENEMETHANAMINEDIHYDROCHLORIDE
(3R)-1-benzyl-N,N-dimethylpyrrolidin-3-amine,dihydrochloride
Ethyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
ethyl 5-<2-(dimethylamino)ethoxy>-1H-indole-2-carboxylate
1,2-o-isopropylidene-3-benzyloxy-5,6-dideoxy-glucofuranose
Ethyl 1-(4-methoxybutyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylate
ETHYL 7-ACETAMIDO-4,5-DIHYDRO-1H-BENZO[D]AZEPINE-3(2H)-CARBOXYLATE
5-tert-butyl-2-[(4-fluorophenyl)methyl]pyrazole-3-carboxylic acid
Tert-butyl 2-(2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)acetate
2-Morpholino-2-(2-(trifluoromethyl)pyrimidin-5-yl)ethanamine
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazol-2-amine
1-(4-isopropylphenyl)-5-phenylpenta-1,4-dien-3-one
TERT-BUTYL ((2-(TRIFLUOROMETHYL)PYRIDIN-4-YL)METHYL)CARBAMATE
Methyl 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
Y-26763
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
6-fluoro-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole
4-Trimethylsilylphenylboronic acid pinacol ester
C15H25BO2Si (276.17167800000004)
N-(4-TERT-BUTYL-PHENYL)-6-CHLORO-PYRIMIDINE-2,4-DIAMINE
Tris(isopropenyloxy)(phenyl)silane
C15H20O3Si (276.11816500000003)
TERT-BUTYL ((6-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHYL)CARBAMATE
2-[4-[(E)-N-hydroxy-C-methylcarbonimidoyl]phenoxy]-1-piperidin-1-ylethanone
4-(4-CHLOROBENZYL)-3-METHYL-5-((R)-PYRROLIDIN-2-YL)-4H-1,2,4-TRIAZOLE
N-[3-Cyano-3-[4-(dicyanomethyl)phenyl]-2-propenylidene]-N-ethyl-ethaniminium inner salt
2-(2-HYDROXYETHYLAMINO)-6-(ISOPENT-2-ENYLAMINO)-9-METHYLPURINE
(3S,5R)-tert-Butyl4-(chlorocarbonyl)-3,5-dimethylpiperazine-1-carboxylate
Pyrido[2,1-f]purine-2,4,6(1H,3H,7H)-trione,8,9-dihydro-1,3,8,8-tetramethyl-
C13H16N4O3 (276.12223459999996)
(3R)-3-(tert-Butyldimethylsilyl)oxypentanedioate-1-methyl monoester
(3-((2-(PIPERIDIN-1-YL)ETHYL)CARBAMOYL)PHENYL)BORONIC ACID
tert-butyl 2,8-diazaspiro[4.5]decane-2-carboxylatehydrochloride
tert-Butyl 2,8-diazaspiro[4.5]decane-8-carboxylate hydrochloride
Methyl 5-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate
1-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzimidazole
1-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazole
tert-Butyl 2,6-diazaspiro[4.5]decane-6-carboxylate hydrochloride
5-(2-adamantylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione
trimethyl-(2-trimethylsilyl-1-trimethylsilyloxyethenoxy)silane
etintidine
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
TERT-BUTYL 6-AMINO-3,3-DIMETHYL-2-OXOINDOLINE-1-CARBOXYLATE
1,3-diisocyanato-2-methyl-benzene, 2-methyloxirane, oxirane
5-(3-(1-Methylcyclopropyl)propyl)-1H-pyrano(2,3-d)pyrimidine-2,4,7(3H)-trione
N-[(1s)-1-(Aminocarbonyl)-4-(Ethanimidoylamino)butyl]benzamide
(S)-2-((S)-2-Hydroxypropanamido)-3-(1H-indol-3-yl)propanoic acid
7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptanoic acid
[2-(Carbamoyloxymethyl)-4-hydroxy-2-methylpentyl] N-propan-2-ylcarbamate
Butanedioic acid, methyl-, bis(trimethylsilyl) ester
(5R,6R,7S,8S)-5-(Hydroxymethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-A]pyridine-6,7,8-triol
2,4-Dihydroxy-N-[2-(2-mercapto-vinylcarbamoyl)-ethyl]-3,3-dimethyl-butyramide
4-methyl-4-sulfanylpentan-2-one-[CysGly] conjugate
2-[[(2R)-2-amino-3-(2-methyl-4-oxopentan-2-yl)sulfanylpropanoyl]amino]acetic acid
4-Amino-5-(2-amino-3-methylpentanoyl)peroxy-5-oxopentanoic acid
3-Carboxylato-2-(4-carboxybutyryloxy)-N,N,N-trimethyl-1-propaneaminium
[3-Carboxy-2-(2-carboxybutanoyloxy)propyl]-trimethylazanium
(3R)-3-{[(3R)-3-{[(3R)-3-hydroxybutanoyl]oxy}butanoyl]oxy}butanoic acid
A diester resulting from the formal sequential esterification of the hydroxy group of one molecule of (3R)-3-hydroxybutyric acid with the carboxy group of a second, followed by the esterification of the hydroxy group of the product with the carboxy group of a third molecule of (3R)-3-hydroxybutyric acid. Isolated from the Japanese inedible mushroom Hypoxylon truncatum and also the sponge-derived actinomycete Micromonospora sp. RV43.
4-[[(Cyclohexylamino)-oxomethyl]amino]benzoic acid methyl ester
1-Cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea
N-(4-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine
1-[4-[(2-Methyl-4-quinolinyl)amino]phenyl]ethanone
5-methyl-3-(2-morpholino-2-oxoethyl)-1,3-benzoxazol-2(3H)-one
5-[(2,4-Diaminopyrimidin-5-yl)methyl]-2,3-dimethoxyphenol
C13H16N4O3 (276.12223459999996)
N-(2-methoxyethyl)-5-(3-methoxyphenyl)-1,2-oxazole-3-carboxamide
N-(3-methylphenyl)-4-tetrazolo[1,5-a]quinoxalinamine
(1-Methylsulfonyl-4-piperidinyl)-(4-morpholinyl)methanone
N-cyclohexyl-N,4-dimethyl-5-thieno[3,2-b]pyrrolecarboxamide
5-Amino-1-ethyl-3-(1-naphthalenylmethyl)-4-pyrazolecarbonitrile
6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoic acid
(5R)-5-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexanoic acid
7-[(2E)-2-[(2-methylphenyl)methylidene]hydrazinyl]-7-oxoheptanoic acid
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-methoxyethanone
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-methoxyethanone
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-4-methyl-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-methoxyethanone
[(2S)-3-carboxy-2-(4-carboxybutanoyloxy)propyl]-trimethylazanium
[(2R)-3-carboxy-2-(4-carboxybutanoyloxy)propyl]-methyl-bis(trideuteriomethyl)azanium
Ethyl 1,2,7-trimethyl-4-nitro-1H-indole-3-carboxylate
alpha-Cyclopentylphenylacetic acid trimethylsilyl ester
3-Benzyl-6-methyl-1,2,3,4-tetrahydro-gamma-carboline
3,3-Dimethyl-1-phenyl-1,2,3,4-tetrahydro-gamma-carboline
5-Amino-6-(D-ribitylamino)uracil
C9H16N4O6 (276.10697960000005)
An aminouracil that is D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminouracil. Early intermediate in bacterial riboflavin synthesis.
2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-fluoroaniline
C15H17FN2S (276.10964140000004)
7-[2-[(2-methylphenyl)methylidene]hydrazinyl]-7-oxoheptanoic acid
carboxylato-PTIO
A benzoate that is the conjugate base of carboxy-PTIO, obtained by deprotonation of the carboxy group.
6-hydroxy-8-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-2,2-dimethyl-3h-1-benzopyran-4-one
(4as,8s,10s,10as,10br)-10-hydroxy-8-(hydroxymethyl)-4a,10b-dimethyl-8h,9h,10h,10ah-cyclohexa[f]chromen-1-one
(2r)-1-[(2s)-4,6-dihydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-2-methylbutan-1-one
(3s,6s)-3-[(2s)-butan-2-yl]-6-[(4-hydroxyphenyl)methyl]-3,6-dihydropyrazine-2,5-diol
(1r,11r,12e,17s)-12-ethylidene-10-methylidene-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,8-tetraene
(3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-3,6-dihydropyrazine-2,5-diol
(2s)-4-[(2e)-but-2-enoyl]-2-[(1e,3e)-hexa-1,3-dien-1-yl]-5-methoxy-2-methylfuran-3-one
5-hydroxy-7,7,9,9-tetramethyl-1h,2h,3h,10bh-pyrrolo[1,2-c]quinazoline-8,10-dione
(1r,6s,11as,14ar)-1-hydroxy-6-methyl-1h,6h,7h,11ah,12h,14h,14ah-cyclopenta[f]oxacyclotridecane-4,13-dione
(1r,11s,16s,18e)-18-ethylidene-2-methylidene-4,14-diazapentacyclo[12.3.1.0³,¹¹.0⁵,¹⁰.0¹¹,¹⁶]octadeca-3,5,7,9-tetraene
4-[(2e)-but-2-enoyl]-2-[(1e,3e)-hexa-1,3-dien-1-yl]-5-methoxy-2-methylfuran-3-one
5-[(5-amino-2,6-dihydroxypyrimidin-4-yl)amino]pentane-1,2,3,4-tetrol
C9H16N4O6 (276.10697960000005)
9a-methoxy-3,4a,5-trimethyl-4h,5h,8ah,9h-naphtho[2,3-b]furan-2,6-dione
(6ar,7s,10as)-7,10a-dimethyl-2-oxo-4h,6h,6ah,8h,9h,10h-cyclohexa[f]isochromene-7-carboxylic acid
(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2e)-2-methylbut-2-enoate
(2r,8s,8ar)-5-acetyl-3,8-dimethyl-6-oxo-2,7,8,8a-tetrahydro-1h-naphthalen-2-yl acetate
1-[(2s)-6,7-dimethoxy-2-methylchromen-2-yl]-2-methylpropan-1-one
(11r,13s)-4-isopropyl-13-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
4-isopropyl-11-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
1-(5-hydroxy-7-methoxy-2,2-dimethylchromen-6-yl)-2-methylpropan-1-one
(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2z)-2-methylbut-2-enoate
9,9-dimethyl-5-(3-methylbut-3-en-1-yn-1-yl)-2,8-dioxatricyclo[5.4.0.0¹,³]undec-5-ene-4,10-diol
(2r,3r,4s,5s,6r)-2-{[(1r,6s)-6-hydroxycyclohex-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
11-(3-hydroxy-2-oxobutyl)-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one
8-(2,5-dihydroxyphenyl)-6-hydroxy-2,6-dimethylocta-2,7-dienal
(11r,12e,17s)-12-ethylidene-10-methylidene-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,8-tetraene
2-(6,7-dihydroxy-7-methyl-3-methylideneoct-1-yn-1-yl)benzene-1,4-diol
(1r,9s)-11-[(3s)-3-hydroxy-2-oxobutyl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one
(4s,11r,13s)-4-isopropyl-13-methoxy-11-methyl-3,12-dioxatricyclo[7.4.0.0²,⁶]trideca-1,6,8-trien-5-one
methyl 2-[(2r,3r,4as)-3-hydroxy-4a,8-dimethyl-7-oxo-1,2,3,4-tetrahydronaphthalen-2-yl]prop-2-enoate
(2s,3r,3ar,6s)-2,7,8-trihydroxy-3,6,9-trimethyl-2,3,3a,4,5,6-hexahydrophenalen-1-one
methyl (2e)-3-{3-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-4-methoxyphenyl}prop-2-enoate
3-(3-methylbut-2-en-1-yl)-4-[(2-methylpropanoyl)oxy]benzoic acid
6,8-dimethoxy-2-methyl-3-(2-methylpropyl)chromen-4-one
(4as,5s,8s,8ar)-8-methoxy-3,5,8a-trimethyl-4ah,5h,6h,7h,8h-naphtho[2,3-b]furan-4,9-dione
1-(2-{[(6s)-6-hydroxy-2-methylcyclohex-1-en-1-yl]oxy}-5-methoxyphenyl)ethanone
methyl 2-[(5s,6s,7ar)-6-ethenyl-3,6-dimethyl-2-oxo-4,5,7,7a-tetrahydro-1-benzofuran-5-yl]prop-2-enoate
(e)-({[(1s,2r,3r)-1-carboxy-2-hydroxy-1,4-dimethylpentan-3-yl]-c-hydroxycarbonimidoyl}methylidene)(methoxy)oxidoazanium
methyl (2z,3s,4s,5e)-4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
ethyl 2-[(1r,9r)-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl]acetate
(2z)-n-(4-carbamimidamidobutyl)-3-(4-hydroxyphenyl)prop-2-enimidic acid
5-acetyl-3,8-dimethyl-6-oxo-2,7,8,8a-tetrahydro-1h-naphthalen-2-yl acetate
3-(3,4-dimethoxyphenyl)prop-2-en-1-yl 2-methylbut-2-enoate
n-(4-carbamimidamidobutyl)-3-(4-hydroxyphenyl)prop-2-enimidic acid
methyl (2e,3r,4s,5e)-4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
6,7-dimethoxy-2-methyl-2-(2-methylprop-1-en-1-yl)-3h-1-benzopyran-4-one
1-[4,6-dihydroxy-2-(prop-1-en-2-yl)-2,3-dihydro-1-benzofuran-5-yl]-2-methylbutan-1-one
(3r)-3-[(3-{[(3r)-3-hydroxybutanoyl]oxy}butanoyl)oxy]butanoic acid
(1r,3r,4as,5r,7s,7as)-3,4a,5-trihydroxy-1-methoxy-7-methyl-hexahydrocyclopenta[c]pyran-7-yl acetate
(2e,4e,6e,8e,10e)-12-methoxy-3,5,9-trimethyl-12-oxododeca-2,4,6,8,10-pentaenoic acid
(2s,3r,4s,5r,6r)-2-{[(1r,4r)-4-hydroxy-1-methylcyclopent-2-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
methyl 3-(5-methoxy-2,2-dimethylchromen-6-yl)propanoate
1-(6,7-dimethoxy-2-methylchromen-2-yl)-2-methylpropan-1-one
18-ethylidene-2-methylidene-4,14-diazapentacyclo[12.3.1.0³,¹¹.0⁵,¹⁰.0¹¹,¹⁶]octadeca-3,5,7,9-tetraene
methyl 4-hydroxy-2-(methoxymethylidene)-3-methyl-6-phenylhex-5-enoate
ethyl 2-{6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-11-yl}acetate
(3as,5s,5as,9ar)-3a-methoxy-1,5,8-trimethyl-4h,5h,5ah,6h,9ah-naphtho[2,1-b]furan-2,7-dione
(1r,11s,12e,17s)-12-ethylidene-10-methylidene-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,8-tetraene
5-(2-hydroxypropan-2-yl)-11,11-dimethyl-4,10-dioxatricyclo[7.4.0.0³,⁷]trideca-1,3(7),8-trien-13-one
(2e)-8-(2,5-dihydroxyphenyl)-6-hydroxy-2,6-dimethylocta-2,7-dienal
(1r,11s,17s)-12-ethylidene-10-methylidene-8,14-diazapentacyclo[9.5.2.0¹,⁹.0²,⁷.0¹⁴,¹⁷]octadeca-2,4,6,8-tetraene
(2r,3s,4s)-5-[(5-amino-2,6-dihydroxypyrimidin-4-yl)amino]pentane-1,2,3,4-tetrol
C9H16N4O6 (276.10697960000005)